-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Kyverna Therapeutics, Inc. quarterly Assets, Current history and growth rate from Q4 2023 to Q2 2024.
- Kyverna Therapeutics, Inc. Assets, Current for the quarter ending June 30, 2024 was $349M.